• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病与睡眠障碍:对可能存在的疾病关联和潜在治疗靶点的深入了解。

Alzheimer's disease and sleep disorders: Insights into the possible disease connections and the potential therapeutic targets.

机构信息

National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana, India.

Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha, India.

出版信息

Asian J Psychiatr. 2022 Feb;68:102961. doi: 10.1016/j.ajp.2021.102961. Epub 2021 Dec 2.

DOI:10.1016/j.ajp.2021.102961
PMID:34890930
Abstract

One of the comorbid conditions in an individual with Alzheimer's disease is a sleep disorder. Clinical features of sleep disorders involve various sleep disturbances such as Obstructive Sleep Apnea (OSAS), Excessive Daytime Sleepiness (EDS), Rapid Eye Movement (REM), Breathing Disorders, Periodic limb movements in sleep (PLMS), etc. The primary tools used for the identification of such disturbances are Polysomnography (PSG) and Wrist actigraphy. This review will highlight and explains the different approaches used in the treatment of sleep disorders. Non-pharmacological treatments include Peter Hauri rules, sleep education program, and light therapy which play a key role in the regulation of sleep-wake cycles. Pharmacological therapy described in this article may be useful in treating sleep destruction in patients with Alzheimer's disease. Along with the Non-pharmacological and pharmacological treatment, here we discuss five commonly recognized plant-based nutraceuticals with hypothesized impact on sleep disorders: caffeine, chamomile, cherries, L-tryptophan, and valerian by the proper emphasis on the known mechanism of their action.

摘要

阿尔茨海默病患者的合并症之一是睡眠障碍。睡眠障碍的临床特征包括各种睡眠紊乱,如阻塞性睡眠呼吸暂停(OSAS)、日间嗜睡(EDS)、快速眼动(REM)、呼吸障碍、睡眠中周期性肢体运动(PLMS)等。用于识别这些干扰的主要工具是多导睡眠图(PSG)和腕部动作描记法。这篇综述将重点介绍和解释治疗睡眠障碍的不同方法。非药物治疗包括彼得·豪里规则、睡眠教育计划和光照疗法,它们在调节睡眠-觉醒周期中起着关键作用。本文描述的药物治疗可能对治疗阿尔茨海默病患者的睡眠破坏有用。除了非药物和药物治疗外,我们还讨论了五种常见的基于植物的营养保健品,它们被认为对睡眠障碍有影响:咖啡因、洋甘菊、樱桃、色氨酸和缬草,并适当强调了它们作用的已知机制。

相似文献

1
Alzheimer's disease and sleep disorders: Insights into the possible disease connections and the potential therapeutic targets.阿尔茨海默病与睡眠障碍:对可能存在的疾病关联和潜在治疗靶点的深入了解。
Asian J Psychiatr. 2022 Feb;68:102961. doi: 10.1016/j.ajp.2021.102961. Epub 2021 Dec 2.
2
Myotonic dystrophytype 1 - report of non-24-h sleep-wake disorder with excessive daytime sleepiness.1 型肌强直性营养不良 - 报告非 24 小时睡眠-觉醒障碍伴日间过度嗜睡。
Chronobiol Int. 2018 Sep;35(9):1326-1328. doi: 10.1080/07420528.2018.1471088. Epub 2018 May 15.
3
Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer's disease.睡眠纺锤波、K 复合波、肢体运动和睡眠阶段比例可能是遗忘型轻度认知障碍和阿尔茨海默病的生物标志物。
Sleep Breath. 2020 Jun;24(2):637-651. doi: 10.1007/s11325-019-01970-9. Epub 2019 Nov 30.
4
Disorders of excessive daytime sleepiness--an update.日间过度嗜睡障碍——最新进展
J Neurol Sci. 1998 Jan 8;153(2):192-202. doi: 10.1016/s0022-510x(97)00291-8.
5
Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation.1 型肌强直性营养不良,日间嗜睡和 REM 睡眠失调。
Sleep Med Rev. 2012 Dec;16(6):539-45. doi: 10.1016/j.smrv.2012.01.001. Epub 2012 Mar 31.
6
Clinical and polysomnographic characteristics of excessive daytime sleepiness in children.儿童日间过度嗜睡的临床和多导睡眠图特征
Sleep Breath. 2017 Dec;21(4):967-974. doi: 10.1007/s11325-017-1545-y. Epub 2017 Aug 18.
7
Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?伴有日间过度嗜睡的帕金森症——一种发作性睡病样障碍?
J Neurol. 2005 Feb;252(2):139-45. doi: 10.1007/s00415-005-0614-5.
8
Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview.帕金森病中的睡眠障碍与日间过度嗜睡:综述
J Neural Transm Suppl. 2006(70):349-55. doi: 10.1007/978-3-211-45295-0_53.
9
Approach to Common Sleep Disorders.常见睡眠障碍处理方法。
Semin Neurol. 2021 Dec;41(6):781-794. doi: 10.1055/s-0041-1726364. Epub 2021 Nov 26.
10
Polysomnographic Findings and Clinical Correlates in Huntington Disease: A Cross-Sectional Cohort Study.亨廷顿病的多导睡眠图结果及其临床关联:一项横断面队列研究
Sleep. 2015 Sep 1;38(9):1489-95. doi: 10.5665/sleep.4996.

引用本文的文献

1
Sleep disorders and Alzheimer's disease: relationship and mechanisms involving neuroinflammation, orexin and Aβ.睡眠障碍与阿尔茨海默病:涉及神经炎症、食欲素和β淀粉样蛋白的关系及机制
Fluids Barriers CNS. 2025 Jun 20;22(1):62. doi: 10.1186/s12987-025-00638-9.
2
Sleep disturbances and their correlation with memory impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment.阿尔茨海默病和遗忘型轻度认知障碍患者的睡眠障碍及其与记忆损害的相关性。
J Alzheimers Dis Rep. 2025 Jan 13;9:25424823241309063. doi: 10.1177/25424823241309063. eCollection 2025 Jan-Dec.
3
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer's Disease, a Potential Therapeutic Target.
谷氨酸:阿尔茨海默病中的分子机制与信号通路,一个潜在的治疗靶点。
Molecules. 2024 Dec 5;29(23):5744. doi: 10.3390/molecules29235744.
4
Unraveling the nexus of age, epilepsy, and mitochondria: exploring the dynamics of cellular energy and excitability.解析年龄、癫痫与线粒体之间的关系:探索细胞能量与兴奋性的动态变化。
Front Pharmacol. 2024 Sep 5;15:1469053. doi: 10.3389/fphar.2024.1469053. eCollection 2024.
5
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.阿尔茨海默病的最新进展:机制、临床试验和新药研发策略。
Signal Transduct Target Ther. 2024 Aug 23;9(1):211. doi: 10.1038/s41392-024-01911-3.
6
Respiratory Dysfunction in Alzheimer's Disease-Consequence or Underlying Cause? Applying Animal Models to the Study of Respiratory Malfunctions.阿尔茨海默病中的呼吸功能障碍——是后果还是潜在原因?应用动物模型研究呼吸功能障碍。
Int J Mol Sci. 2024 Feb 16;25(4):2327. doi: 10.3390/ijms25042327.
7
Mitophagy regulation in aging and neurodegenerative disease.衰老与神经退行性疾病中的线粒体自噬调控
Biophys Rev. 2023 Apr 4;15(2):239-255. doi: 10.1007/s12551-023-01057-6. eCollection 2023 Apr.